Item 8.01 Other Events.
As previously, disclosed, on October 23, 2019, Neurotrope, Inc. (the "Company")
received a notification letter from The Nasdaq Stock Market ("Nasdaq") informing
the Company that for the last 30 consecutive business days, the bid price of the
Company's securities had closed below $1.00 per share, which is the minimum
required closing bid price for continued listing on The Nasdaq Capital Market
pursuant to Listing Rule 5550(a)(2).
On January 17, 2020, the Company received a notification letter from Nasdaq
informing the Company that for the last ten consecutive business days, the
closing bid price of the Company's common stock was $1.00 or greater.
Accordingly, the Company has regained compliance with Nasdaq Listing Rule
5550(a)(2).
© Edgar Online, source Glimpses
NEUROTROPE, INC. 
